NanoViricides
NNVC
#10123
Rank
A$33.47 M
Marketcap
A$1.86
Share price
-1.18%
Change (1 day)
-19.98%
Change (1 year)

NanoViricides (NNVC) - Total assets

Total assets on the balance sheet as of September 2025 : A$12.58 Million

According to NanoViricides's latest financial reports the company's total assets are A$12.58 Million. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

NanoViricides - Total assets on balance sheet (from 2006 to 2025)

Total assets by year

Year Total assets Change
2024-06-30A$19.21 M-24.24%
2023-06-30A$25.35 M-25.55%
2022-06-30A$34.06 M-15.61%
2021-06-30A$40.36 M16.49%
2020-06-30A$34.64 M80.95%
2019-06-30A$19.14 M-23.57%
2018-06-30A$25.05 M-28.77%
2017-06-30A$35.17 M-28.49%
2016-06-30A$49.18 M-14.36%
2015-06-30A$57.42 M23.47%
2014-06-30A$46.51 M158.8%
2013-06-30A$17.97 M17.78%
2012-06-30A$15.26 M52.03%
2011-06-30A$10.03 M-5.45%
2010-06-30A$10.61 M186.17%
2009-06-30A$3.7 M141.65%
2008-06-30A$1.53 M-3.73%
2007-06-30A$1.59 M-56.79%
2006-06-30A$3.69 M
2005-06-30N/A

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
BioCryst Pharmaceuticals
BCRX
A$0.67 B 5,241.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
A$1.77 B 14,018.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$88.15 B 700,300.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$145.91 B 1,159,264.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$195.09 B 1,550,034.74%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
A$124.18 B 986,613.06%๐Ÿ‡ฌ๐Ÿ‡ง UK